Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Dong-A ST

Status: Enrolling

Conditions: Idiopathic Short Stature; Small for Gestational Age; Turner Syndrome; Growth Hormone Deficiency

Study type: Observational

Funder types: Industry

Identifiers

NCT04798690

DA3002_SS_OS

Details and patient eligibility

About

This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.

Enrollment: 2,500 estimated patients

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
• Children who has official height record at least 6 months prior

Exclusion criteria

• Children with Epiphyseal closure

Trial design

2,500 participants in 1 patient group

Growth hormone

Description:

Growtropin®-II